title: Gut-liver interaction in triglyceride-rich lipoprotein metabolism.
abstract: The liver and intestine have complementary and coordinated roles in lipoprotein metabolism. Despite their highly specialized functions, assembly and secretion of triglyceride-rich lipoproteins (TRL; apoB-100-containing VLDL in the liver and apoB-48-containing chylomicrons in the intestine) are regulated by many of the same hormonal, inflammatory, nutritional, and metabolic factors. Furthermore, lipoprotein metabolism in these two organs may be affected in a similar fashion by certain disorders. In insulin resistance, for example, overproduction of TRL by both liver and intestine is a prominent component of and underlies other features of a complex dyslipidemia and increased risk of atherosclerosis. The intestine is gaining increasing recognition for its importance in affecting whole body lipid homeostasis, in part through its interaction with the liver. This review aims to integrate recent advances in our understanding of these processes and attempts to provide insight into the factors that coordinate lipid homeostasis in these two organs in health and disease.
authors.affiliation: Toronto General Hospital, ON, Canada.
authors.forename: Changting
authors.initials: C
authors.lastname: Xiao
authors.forename: Joanne
authors.initials: J
authors.lastname: Hsieh
authors.forename: Khosrow
authors.initials: K
authors.lastname: Adeli
authors.forename: Gary F
authors.initials: GF
authors.lastname: Lewis
mesh_terms: D000818:Animals; D001055:Apolipoproteins B / Q000378:metabolism; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism*; D008074:Lipoproteins / Q000378:metabolism*; D008099:Liver / Q000378:metabolism*; D014280:Triglycerides / Q000378:metabolism*
chemical_list: D001055:Apolipoproteins B; D008074:Lipoproteins; D014280:Triglycerides